AMRX:NASDAQ
Amneal Pharmaceuticals Inc
$18.71
arrow_upward
+2.35%(+0.43) 1D
$18.87
arrow_upward
+0.86% (+0.16)bedtimeAfter hours
Closed: Sep 18, 4:00:02 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRX...
Open
$18.12
High
$18.81
Low
$18.06
Mkt. cap
6.52B
Avg. vol.
1.81M
Volume
6.62M
P/E ratio
39.04
52-wk high
$19.26
52-wk low
$9.49
EPS
$0.48
Beta
1.24
Shares outstanding
319.35M
No. of employees
9K
Open
$18.12
High
$18.81
Low
$18.06
Mkt. cap
6.52B
Avg. vol.
1.81M
Volume
6.62M
P/E ratio
39.04
52-wk high
$19.26
52-wk low
$9.49
EPS
$0.48
Beta
1.24
Shares outstanding
319.35M
No. of employees
9K
News stories
From web sources and news partners
AD HOC NEWS
·
1 hour ago
Amneal Pharmaceuticals stock gains after FDA approval for lanreotide injection
Simply Wall Street
·
7 hours ago
How Investors May Respond To Amneal Pharmaceuticals (AMRX) FDA Approval Launch
Stock Titan
·
22 hours ago
An injection for three conditions launches immediately after FDA approval
Stocktwits
·
22 hours ago
AMRX Stock Advances As Generic To Ipsen’s Hormone Shot Gets FDA Nod
Profile
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States. Wikipedia
About Amneal Pharmaceuticals Inc
CEOChintu Patel | Chirag Patel
Employees8.7K
Founded2002
HeadquartersBridgewater, New Jersey, United States
SectorPharmaceutical industry
Websiteamneal.com